SMARCA4 and neoplasm: SMARCA4-deficient NSCLC was correlated with male sex, older age, smoking history, larger tumor size, and a higher tumor proliferation index (higher Ki-67), among other clinicopathological features, while patients demonstrated worse prognosis compared to SMARCA4-intact cases [8].